Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
M1 Kliniken AGMKLNF 92 EV-to-EBIT is 9.77 as of Aug. 09, 2026, which is 42% below its 10-year median of 16.79. GuruFocus rates MKLNF with a GF Score™ of 92/100 and a GF Value™ of $9.78. The stock has 3 warning signs investors should review. Among 96 Medical Distribution companies, M1 Kliniken AG ranks better than 57.29% on this metric.
M1 Kliniken AG (OTCPK:MKLNF) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
M1 Kliniken AG's Enterprise Value for the quarter that ended in Dec. 2025 was $209.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $41.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG EV-to-EBIT Related Terms
M1 Kliniken AG EV-to-EBIT Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, M1 Kliniken AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG EV-to-EBIT vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's EV-to-EBIT falls into.
M1 Kliniken AG's current Enterprise Value is $404.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. M1 Kliniken AG's EBIT for the trailing twelve months (TTM) ended in Dec. 2025 was $41.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG (MKLNF) has a EV-to-EBIT of 9.77 as of Aug. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on M1 Kliniken AG and its competitors. This is 42% below median its historical median of 16.79. Over the past decade, M1 Kliniken AG's EV-to-EBIT has ranged from 5.24 to 34.87. According to the industry distribution chart, M1 Kliniken AG ranks #41 out of 96 companies in the Medical Distribution industry, placing it in the top 42.7%.
Is M1 Kliniken AG's EV-to-EBIT too high?
M1 Kliniken AG's current EV-to-EBIT of 9.77 is 42% below median its 10-year median of 16.79. Over the past 10 years, this metric has ranged from a low of 5.24 to a high of 34.87. The Medical Distribution industry median EV-to-EBIT is 11.94. M1 Kliniken AG's value of 9.77 is 18.2% below this industry median. Based on the distribution chart, M1 Kliniken AG ranks #41 out of 96 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, M1 Kliniken AG has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's EV-to-EBIT compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #41 out of 96 companies for EV-to-EBIT. This puts M1 Kliniken AG in the upper half of its industry. The industry median EV-to-EBIT is 11.94. M1 Kliniken AG's value of 9.77 is 18.2% below this benchmark. Historically, M1 Kliniken AG's own EV-to-EBIT has ranged from 5.24 to 34.87 over the past decade. While the company's 10-year median is 16.79 vs. the industry median of 11.94, M1 Kliniken AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Medical Distribution company?
The median EV-to-EBIT among Medical Distribution companies is 11.94, based on 96 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current EV-to-EBIT of 9.77 is 18.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median EV-to-EBIT is 11.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current EV-to-EBIT is 9.77, which is 42% below median its own 10-year median of 16.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
M1 Kliniken AG (MKLNF) has a current EV-to-EBIT of 9.77. The stock's GF Value™ is $9.78, compared to a current price of $11.73 — trading 19.9% above its estimated fair value. The current EV-to-EBIT is 9.77, which is 42% below median its 10-year median of 16.79 and 18.2% below the Medical Distribution industry median of 11.94. M1 Kliniken AG's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For M1 Kliniken AG (MKLNF), the current EV-to-EBIT is 9.77 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (MKLNF) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of $11.73 is trading 19.9% above its estimated GF Value™ of $9.78.
Key valuation signals for MKLNF:
EV-to-EBIT: 9.77 (42% below median its 10-year median of 16.79)
GF Value™: $9.78 vs. price of $11.73 (19.9% above fair value)
Industry Position: 18.2% below the Medical Distribution median (#41 of 96)
No single metric tells the full story. See the MKLNF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
92GF Score
Get the complete analysis for MKLNF
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MKLNF has been successfully added to your 
